GIA
UTHR icon

Gargoyle Investment Advisor’s United Therapeutics UTHR Stock Holding History

Gargoyle Investment Advisor’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,173
Closed -$413K – 101
2019
Q3 		$413K Sell
5,173
-5,390
-51% -$434K 0.52% 83
2019
Q2 		$825K Buy
10,563
+90
+0.9% +$8.42K 0.92% 54
2019
Q1 		$1.23M Sell
10,473
-30
-0.3% -$3.5K 1.18% 38
2018
Q4 		$1.14M Buy
+10,503
New +$1.22M 1.05% 38
2018
Q3 		– Sell
-3,765
Closed -$426K – 131
2018
Q2 		$426K Sell
3,765
-60
-2% -$6.59K 0.24% 87
2018
Q1 		$430K Sell
3,825
-1,045
-21% -$133K 0.18% 104
2017
Q4 		$720K Sell
4,870
-3,323
-41% -$422K 0.29% 89
2017
Q3 		$960K Hold
8,193
– – 0.35% 86
2017
Q2 		$1.06M Sell
8,193
-6,200
-43% -$773K 0.42% 80
2017
Q1 		$1.95M Sell
14,393
-1,803
-11% -$273K 0.75% 64
2016
Q4 		$2.32M Sell
16,196
-2,153
-12% -$275K 0.91% 51
2016
Q3 		$2.17M Hold
18,349
– – 0.82% 63
2016
Q2 		$1.94M Buy
18,349
+600
+3% +$66.9K 0.73% 68
2016
Q1 		$1.98M Sell
17,749
-6,943
-28% -$879K 0.67% 77
2015
Q4 		$3.87M Sell
24,692
-585
-2% -$85.2K 1.57% 5
2015
Q3 		$3.32M Sell
25,277
-3,206
-11% -$514K 1.36% 12
2015
Q2 		$4.96M Sell
28,483
-844
-3% -$152K 1.89% 1
2015
Q1 		$5.06M Sell
29,327
-7,038
-19% -$1.07M 1.9% 1
2014
Q4 		$4.71M Hold
36,365
– – 1.72% 6
2014
Q3 		$4.68M Buy
36,365
+7,312
+25% +$754K 1.77% 3
2014
Q2 		$2.67M Sell
29,053
-4,294
-13% -$413K 1% 56
2014
Q1 		$3.14M Sell
33,347
-9,085
-21% -$929K 1.4% 24
2013
Q4 		$4.8M Buy
42,432
+9
+0% +$812 2.27% 3
2013
Q3 		$2.95M Sell
42,423
-839
-2% -$61.3K 1.82% 11
2013
Q2 		$2.85M Buy
+43,262
New +$2.79M 1.44% 24

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Gargoyle Investment Advisor's UTHR Position: Q4 2019 in Review

Gargoyle Investment Advisor sold out of United Therapeutics (UTHR) in Q4 2019, closing a stake of 5,173 shares — an estimated $413K sold.

Gargoyle Investment Advisor first reported a position in UTHR in Q2 2013 and held it in 25 quarters. The position peaked at $5.06M in Q1 2015. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

  • Gargoyle Investment Advisor reported no remaining United Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 5,173 United Therapeutics shares in Q4 2019, an estimated $413K.
  • Gargoyle Investment Advisor first reported a position in United Therapeutics in Q2 2013 and held it in 25 quarters.
  • Gargoyle Investment Advisor's United Therapeutics position peaked at $5.06M in Q1 2015.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2019, filed 18 Feb 2020.